ZA201204018B - Topical foam composition - Google Patents
Topical foam compositionInfo
- Publication number
- ZA201204018B ZA201204018B ZA2012/04018A ZA201204018A ZA201204018B ZA 201204018 B ZA201204018 B ZA 201204018B ZA 2012/04018 A ZA2012/04018 A ZA 2012/04018A ZA 201204018 A ZA201204018 A ZA 201204018A ZA 201204018 B ZA201204018 B ZA 201204018B
- Authority
- ZA
- South Africa
- Prior art keywords
- foam composition
- topical foam
- topical
- composition
- foam
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2703MU2009 | 2009-11-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201204018B true ZA201204018B (en) | 2012-12-27 |
Family
ID=43447946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2012/04018A ZA201204018B (en) | 2009-11-23 | 2012-06-01 | Topical foam composition |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP2503989A2 (en) |
JP (1) | JP2013511570A (en) |
KR (1) | KR20120117788A (en) |
CN (1) | CN102724960A (en) |
AU (1) | AU2010320656B2 (en) |
BR (1) | BR112012012316A2 (en) |
CA (1) | CA2781580A1 (en) |
MX (1) | MX2012005883A (en) |
NZ (1) | NZ600362A (en) |
RU (1) | RU2012126084A (en) |
WO (1) | WO2011061519A2 (en) |
ZA (1) | ZA201204018B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1698630E (en) | 2005-03-03 | 2014-09-15 | Alfa Wassermann Spa | New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
ITBO20050123A1 (en) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | GASTRORESISTIC PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINA |
DE602006006432D1 (en) | 2005-03-24 | 2009-06-04 | Nolabs Ab | COSMETIC TREATMENT WITH STAIN OXIDE, DEVICE FOR CARRYING OUT THIS TREATMENT, AND METHOD OF MANUFACTURING THEREOF |
WO2011022652A1 (en) | 2009-08-21 | 2011-02-24 | Novan, Inc. | Topical gels |
IT1398550B1 (en) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | RIFAXIMINA COMPREHENSIVE FORMULATIONS USEFUL TO OBTAIN A PROLONGED EFFECT IN TIME |
WO2013006608A1 (en) | 2011-07-05 | 2013-01-10 | Novan, Inc. | Topical compositions |
ITBO20110461A1 (en) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | PHARMACEUTICAL COMPOSITIONS INCLUDING RIFAXIMINA, PROCESSES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS. |
JP6265967B2 (en) * | 2012-03-14 | 2018-01-24 | ノヴァン,インコーポレイテッド | Pharmaceutical composition |
ITBO20120368A1 (en) | 2012-07-06 | 2014-01-07 | Alfa Wassermann Spa | COMPOSITIONS INCLUDING RIFAXIMINA AND AMINO ACIDS, RIFAXIMINE CRYSTALS DERIVING FROM SUCH COMPOSITIONS AND THEIR USE. |
US9855211B2 (en) | 2013-02-28 | 2018-01-02 | Novan, Inc. | Topical compositions and methods of using the same |
CN105979969B (en) | 2013-08-08 | 2020-09-11 | 诺万公司 | Topical compositions and methods of using the same |
NZ723571A (en) | 2014-05-12 | 2020-02-28 | Alfasigma Spa | New solvated crystal form of rifaximin, production, compositions and uses thereof |
CA2919733A1 (en) | 2014-08-08 | 2016-02-08 | Novan, Inc. | Topical compositions and methods of using the same |
JP7090549B2 (en) | 2016-03-02 | 2022-06-24 | ノヴァン,インコーポレイテッド | Therapeutic compositions for inflammation and their treatment methods |
CN109310630A (en) | 2016-04-13 | 2019-02-05 | 诺万公司 | For treating composition, system, kit and the method for infection |
WO2018109717A1 (en) * | 2016-12-16 | 2018-06-21 | Ferring B.V. | Rectal foam formulations |
US11285171B2 (en) | 2018-03-01 | 2022-03-29 | Novan, Inc. | Nitric oxide releasing suppositories and methods of use thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2907118A1 (en) | 1979-02-20 | 1980-09-04 | Schering Ag | NEW PROSTACYCLINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
IT1154655B (en) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | IMIDAZO-RIFAMYCIN DERIVATIVES METHODS FOR THEIR PREPARATION AND USE AS AN ANTIBACTERIAL ACTION SUBSTANCE |
IT1199374B (en) | 1984-05-15 | 1988-12-30 | Alfa Farmaceutici Spa | PROCESS FOR THE PREPARATION OF PIRIDO-IMIDAZO-RIFAMICINE |
GB8909559D0 (en) | 1989-04-26 | 1989-06-14 | Smith Kline French Lab | Pharmaceutical compositions |
FR2647344B1 (en) | 1989-05-25 | 1995-06-02 | Physiopharm Sarl | RECTAL USE AEROSOL FOAM |
US4946939A (en) | 1989-05-30 | 1990-08-07 | The Dow Chemical Company | High purity polyether polyols |
IT1243379B (en) | 1990-07-27 | 1994-06-10 | Giuliani Spa | PHARMACEUTICAL COMPOSITION SUITABLE FOR RECTAL ADMINISTRATION OF ACTIVE PRINCIPLES WHICH EXPLICATE A MEDICATION ACTION AT THE LEVEL OF THE COLON, PREVALENTLY TOPICAL |
IT1253711B (en) * | 1991-12-17 | 1995-08-23 | Alfa Wassermann Spa | VAGINAL PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS |
IT1264494B1 (en) | 1993-03-23 | 1996-09-24 | Alfa Wassermann Spa | USE OF RIFAXIMIN AND FORMULATIONS THAT CONTAIN IT IN THE TREATMENT OF GASTRIC DYSPEPSIES ORIGINATED BY HELICOBACTER |
IT1290679B1 (en) | 1997-02-14 | 1998-12-10 | Alfa Wassermann Spa | USE OF RIFAXIMINE AND OF THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT IN THE TREATMENT OF DIARRHEA FROM CRYPTOSPORIDIOSIS. |
US7820145B2 (en) * | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US20070292461A1 (en) * | 2003-08-04 | 2007-12-20 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
ITMI20032144A1 (en) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | REFLEXIMINE POLIMORPHIC FORMS, PROCESSES TO OBTAIN THEM AND |
PT1698630E (en) | 2005-03-03 | 2014-09-15 | Alfa Wassermann Spa | New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
US8987292B2 (en) * | 2006-03-09 | 2015-03-24 | Salix Pharmaceuticals, Ltd. | Rifaximin anti-rectal dysfunction preparation |
SI2294012T1 (en) * | 2008-05-07 | 2014-11-28 | Salix Pharmaceuticals, Ltd. | Administration of a bowel cleanser and an antibiotic for the treatment of bowel disease |
CN101502510B (en) * | 2009-03-19 | 2011-11-09 | 山东京卫制药有限公司 | Medicament composition for treating colpitis symptoms and preparation method thereof |
-
2010
- 2010-11-23 NZ NZ600362A patent/NZ600362A/en not_active IP Right Cessation
- 2010-11-23 CN CN2010800581391A patent/CN102724960A/en active Pending
- 2010-11-23 BR BR112012012316A patent/BR112012012316A2/en not_active IP Right Cessation
- 2010-11-23 CA CA2781580A patent/CA2781580A1/en not_active Abandoned
- 2010-11-23 JP JP2012540490A patent/JP2013511570A/en active Pending
- 2010-11-23 RU RU2012126084/15A patent/RU2012126084A/en unknown
- 2010-11-23 EP EP10784333.6A patent/EP2503989A2/en not_active Withdrawn
- 2010-11-23 KR KR1020127016200A patent/KR20120117788A/en not_active Application Discontinuation
- 2010-11-23 MX MX2012005883A patent/MX2012005883A/en not_active Application Discontinuation
- 2010-11-23 AU AU2010320656A patent/AU2010320656B2/en not_active Expired - Fee Related
- 2010-11-23 WO PCT/GB2010/002164 patent/WO2011061519A2/en active Application Filing
-
2012
- 2012-06-01 ZA ZA2012/04018A patent/ZA201204018B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2503989A2 (en) | 2012-10-03 |
BR112012012316A2 (en) | 2016-04-26 |
KR20120117788A (en) | 2012-10-24 |
AU2010320656A1 (en) | 2012-06-21 |
CA2781580A1 (en) | 2011-05-26 |
AU2010320656B2 (en) | 2015-07-30 |
JP2013511570A (en) | 2013-04-04 |
NZ600362A (en) | 2014-08-29 |
WO2011061519A3 (en) | 2011-10-06 |
CN102724960A (en) | 2012-10-10 |
WO2011061519A2 (en) | 2011-05-26 |
MX2012005883A (en) | 2012-10-09 |
RU2012126084A (en) | 2013-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL214520A0 (en) | Topical foam composition | |
ZA201204018B (en) | Topical foam composition | |
GB0911562D0 (en) | Foam composition | |
GB0908129D0 (en) | Composition | |
GB0918450D0 (en) | Composition | |
GB0913255D0 (en) | Topical composition | |
GB0911428D0 (en) | Composition | |
ZA201204017B (en) | Topical foam composition | |
GB0909362D0 (en) | Composition | |
GB201020601D0 (en) | Topical formulation | |
GB0908642D0 (en) | Composition | |
GB0901966D0 (en) | Composition | |
EP2394634A4 (en) | Hesperidin-containing composition | |
GB0906779D0 (en) | Composition | |
GB0922389D0 (en) | composition | |
GB0911294D0 (en) | Composition | |
GB0904941D0 (en) | Composition | |
EP2444061A4 (en) | Apigenin-containing composition | |
GB201006350D0 (en) | Composition | |
GB0904942D0 (en) | Composition | |
GB0918590D0 (en) | Composition | |
GB0903688D0 (en) | Composition | |
IL197464A0 (en) | Foamable topical composition | |
GB0922133D0 (en) | Composition | |
GB0902959D0 (en) | Composition |